Haematopoietic cell lines are the workhorses of immunology, haematology, and cell-death biology. Unlike the adherent solid-tumour lines that dominate a cell-culture incubator, most of them grow in suspension — they do not attach to plastic, they are passaged by dilution rather than trypsinisation, and their phenotype is defined by lineage markers rather than by cell shape. This catalogue groups the common blood and immune lines by lineage, summarises the markers and canonical uses of each, and flags the caveats that trip people up.
Why suspension culture is different
- Passaging by dilution. Cells are split by transferring a fraction of the conditioned medium into fresh medium; trypsin is never used and would damage the surface receptors many assays depend on. Keep density within a defined window — most lines are unhappy below ~2 × 105/mL and overgrow or die above ~1–2 × 106/mL.
- Clumping. Lines such as K-562, Jurkat, and THP-1 clump at high density. Gentle pipetting or a brief low-speed spin disperses them; vigorous vortexing creates debris that confounds flow cytometry.
- Phenotypic drift. Suspension lines are notoriously prone to losing marker expression or acquiring resistance to differentiation stimuli over long culture. Keep low-passage stocks and re-authenticate by STR.
- Viability as the key readout. Because these lines are used for killing assays, activation assays, and cytokine readouts, viability and surface-marker staining are the primary quality controls.
T-cell lines
T-cell lines model T-cell receptor signalling, activation-induced cell death, and leukaemia biology. They are the standard source of Jurkat nuclear extracts for NFAT and AP-1 reporter assays.
- Jurkat — an acute T-cell leukaemia line, CD3+, CD4+; the reference model for TCR signal transduction, IL-2 production, calcium flux, and Fas-mediated apoptosis. Caveat: Jurkat is not a normal T cell; it is defective in PTEN and is relatively resistant to some death stimuli.
- CCRF-CEM — a CD4+ T-lymphoblast leukaemia line used in drug-resistance and folate-transport studies.
- MOLT-4 — a CD4+, CD8− T-lymphoblast line widely used as a HIV-1 permissive model and in apoptosis research.
- H9 / HuT-78 — mature CD4+ T-cell lines, both highly permissive for HIV-1 and used for virus-replication and latency studies.
B-cell lines
B-cell lines span the spectrum from Burkitt lymphoma to diffuse large B-cell lymphoma (DLBCL), and are the standard source of B-cell receptors, MHC class II, and EBV biology.
- Raji — a Burkitt lymphoma line, CD19+, CD20+, HLA class II+, carrying a non-productive EBV genome. Because it expresses CD20 and Fc receptors it is the classic ADCC and CDC target for anti-CD20 antibody work and a standard NK-cell killing target.
- Daudi — a Burkitt lymphoma line that, notably, does not express HLA class I at the surface; used for NK-cell education and missing-self studies.
- Namalwa — a Burkitt lymphoma line producing low levels of interferon and used for B-cell differentiation and EBV studies.
- SU-DHL-4 / U2932 — DLBCL lines representing the germinal-centre B-cell (GCB) and activated B-cell (ABC) subtypes respectively; used to model the molecular heterogeneity of DLBCL and to test BCR-pathway inhibitors.
Myeloid lines
Myeloid lines cover the granulocytic, monocytic, and megakaryocytic branches and are the backbone of differentiation and phagocytosis research.
- K-562 — derived from a chronic myeloid leukaemia (CML) in blast crisis, carrying the Philadelphia chromosome and the BCR-ABL fusion; the canonical model for imatinib and other tyrosine-kinase-inhibitor studies, and for erythroid/megakaryocytic differentiation. Caveat: K-562 lacks classical MHC class I and is famously used as a standard NK-cell target in cytotoxicity assays.
- HL-60 — a promyelocytic leukaemia line that differentiates to granulocytes with DMSO or retinoic acid and to monocytes with phorbol esters; used for neutrophil biology, ATRA differentiation, and apoptosis.
- NB-4 — an acute promyelocytic leukaemia line carrying the PML-RARA translocation; the model for all-trans-retinoic acid differentiation and arsenic-trioxide therapy.
- THP-1 — an acute monocytic leukaemia line; a PMA (phorbol myristate acetate) pulse drives it to an adherent, macrophage-like cell with phagocytic capacity. It is the most widely used human macrophage model, though the PMA-differentiated cell is a transformation product, not a primary macrophage.
- U937 — a histiocytic lymphoma line that differentiates along the monocyte/macrophage path with PMA or vitamin D3 and is used for cytokine and phagocytosis studies.
- U266 / RPMI-8226 — myeloma lines, both EBV-negative, used as models for multiple myeloma, plasma-cell biology, and the unfolded-protein and antibody-secretion pathways.
Macrophage lines
These are adherent monocyte/macrophage lines used for phagocytosis, polarisation, and inflammatory-signalling experiments.
- RAW264.7 — a mouse leukaemia-virus-induced macrophage line; the workhorse for TLR signalling, NF-κB activation, and NO production.
- J774A.1 — a mouse macrophage-like line used for phagocytosis, antigen presentation, and intracellular-pathogen killing assays.
- Ana-1 — an immortalised mouse macrophage line used in innate-immunity and cytokine studies.
- THP-1-derived macrophages — as above; the human counterpart to the mouse lines, obtained by PMA differentiation.
NK cells and hybridoma lines
- NK-92 — a human NK-cell line that is IL-2 dependent and cytotoxic against a wide range of targets; it is used both as an effector in cytotoxicity assays and as a platform for engineered cellular therapy. Caveat: it lacks most KIRs and is an immortalised line, so its receptor repertoire differs from primary NK cells.
- YAC-1 — a mouse lymphoma line that is the classical NK-sensitive target in standard 51Cr-release or fluorescence-based cytotoxicity assays; its low MHC class I makes it a model "missing-self" target.
Common caveats
- Lineage markers are not absolute. Many lines are cross-contaminated or misidentified; authenticate by STR (for human lines) and confirm lineage markers by flow cytometry before every campaign.
- PMA differentiation is not a faithful macrophage. Differentiated THP-1 and U937 cells are convenient but differ transcriptionally and functionally from monocyte-derived macrophages.
- Effector/target mismatch. K-562 (human, MHC-low) and YAC-1 (mouse, MHC-low) are NK targets; Raji is an ADCC target. Using the wrong combination invalidates a cytotoxicity result.
- Mycoplasma and viability. Suspension lines are especially vulnerable to mycoplasma, which silently alters activation and cytokine readouts. Screen regularly.
References
- Schneider U, Schwenk HU, Bornkamm G. Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int J Cancer. 1977;19(5):621–626. doi:10.1002/ijc.2910190505
- Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 1975;45(3):321–334. doi:10.1182/blood.v45.3.321.321
- Collins SJ, Gallo RC, Gallagher RE. Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide. J Exp Med. 1979;149(4):969–974. doi:10.1084/jem.149.4.969
- Collins SJ, Ruscetti FW, Gallagher RE, Gallo RC. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci U S A. 1978;75(5):2458–2462. doi:10.1073/pnas.75.5.2458
- Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer. 1980;26(2):171–176. doi:10.1002/ijc.2910260208
- Azari S, Ahmadi N, Tehrani MJ, Shokri F. Profiling and authentication of human cell lines using short tandem repeat (STR) loci: report from the National Cell Bank of Iran. Biologicals. 2007;35(3):195–202. doi:10.1016/j.biologicals.2006.10.001